Search Results

Cover Focus

Drug Delivery: Pearls and Projections

Contributors comment on the present use and future potential of this treatment approach.

Malik Y. Kahook, MD; Jason Bacharach, MD; Courtney Bovee, MD; Savak Teymoorian, MD, MBA; John P. Berdahl, MD; Constance Okeke, MD, MSCE; and Steven R. Sarkisian Jr, MD

Seen & Heard

Cover Focus

MIGS: An Identity Still in Crisis?

A roundtable discussion on past definitions, future directions, and insights gained in between.

Arsham Sheybani, MD; Iqbal Ike K. Ahmed, MD, FRCSC; Robert Chang, MD; Larissa Camejo, MD; Shakeel Shareef, MD; Jason Bacharach, MD; and Oluwatosin Smith, MD

The Literature

Updates on Selective Laser Trabeculoplasty

Researchers studied this modality as an initial treatment for open-angle glaucoma and ocular hypertension and evaluated the procedure’s repeatability.

Ahmadreza Moradi, MD, and Jason Bacharach, MD

Eyetube

The Buzz on Eyetube.net

Cover Focus

From Drops to Drug Delivery: Changing the Hearts and Minds of Clinicians

What factors influence a lasting evolution in care?

Jason Bacharach, MD

What Does Interventional Glaucoma Mean to You?

Jason Bacharach, MD; Lauren S. Blieden, MD; Craig Chaya, MD; Steven R. Sarkisian Jr, MD; Ian Conner, MD, PhD; Leonard K. Seibold, MD; and H. George Tanaka, MD

What Does Interventional Glaucoma Mean to You?

Jason Bacharach, MD; Lauren S. Blieden, MD; Craig Chaya, MD; Steven R. Sarkisian Jr, MD; Ian Conner, MD, PhD; Leonard K. Seibold, MD; and H. George Tanaka, MD

The Literature

How Common Systemic Diseases Play Into Glaucomatous Optic Neuropathy

Research sheds light on glaucoma in patients with diabetes or blood pressure abnormalities.

Jonathan Hernandez, MD, and Jason Bacharach, MD

Case Files

Preperimetric Pigmentary Glaucoma

Panelists get two cracks at this tough case.

Steven R. Sarkisian Jr, MD; Jason Bacharach, MD; and Marco Reyes, MD

On The Horizon

New medications give fresh hope for treating glaucoma.

Jason Bacharach, MD

On The Horizon

New medications give fresh hope for treating glaucoma.

Jason Bacharach, MD

Therapeutics Update

Rho Kinase/Norepinephrine Transporter Inhibition for the Treatment of Glaucoma and Ocular Hypertension

An update on the clinical development of a new class of drugs.

Jason Bacharach, MD

Therapeutics Update

Rho Kinase/Norepinephrine Transporter Inhibition for the Treatment of Glaucoma and Ocular Hypertension

An update on the clinical development of a new class of drugs.

Jason Bacharach, MD

Sidebar: Optic Nerve Analysis for SD-OCT Technology

Jason Bacharach, MD

Current Concepts in Laser Trabeculoplasty

Advances in technology make this option an attractive alternative or adjunct to medical therapy.

Jason Bacharach, MD

Current Concepts in Laser Trabeculoplasty

Advances in technology make this option an attractive alternative or adjunct to medical therapy.

Jason Bacharach, MD

Research Results

Highlights of the AGS Annual Meeting

The latest research findings from the 24th annual meeting of the American Glaucoma Society, held February 26th to March 2nd.

Geoffrey T. Emerick, MD

Devices in Development

An update on some of the technologies and procedures being investigated for microinvasive glaucoma surgery.

Rohit Varma, MD, MPH; William J. Flynn, MD; Robert Marquis, MD, PhD; E. Randy Craven, MD; and Jason Bacharach, MD

Devices in Development

An update on some of the technologies and procedures being investigated for microinvasive glaucoma surgery.

Rohit Varma, MD, MPH; William J. Flynn, MD; Robert Marquis, MD, PhD; E. Randy Craven, MD; and Jason Bacharach, MD